You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Selective, reversible competitive dipeptidyl peptidase IV (DP IV) inhibitor (Ki = 130 nM). Inhibits degradation of GIP and GLP-1, enhancing insulin secretion. Improves glucose tolerance, insulin sensitivity and b-cell glucose responsiveness in diabetic fatty rats following oral administration.
Sold with the permission of Probiodrug.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Pederson et al (1998) Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47 1253 PMID: 9703325
Pospisilik et al (2002) Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral Ins sensitivity in the VDF Zucker rat. Diabetes 51 2677 PMID: 12196458
View Related Products by Product Action
Keywords: P32/98, P32/98 supplier, Isoleucyl, thiazolidide, Other, Proteases, 2136, Tocris Bioscience
Citations for P32/98
Citations are publications that use Tocris products.
Currently there are no citations for P32/98.
Reviews for P32/98
There are currently no reviews for this product. Be the first to review P32/98 and earn rewards!
Have you used P32/98?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image